Genetic database gives hope for potential Parkinson’s treatment

News

Author: Saskia MairPublished: 4 June 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

DNA molecules genetic database

The Genome Aggregation Database (gnomAD) – the world’s largest public database of variations in DNA which can cause diseases – has given scientists hope for a potential Parkinson’s treatment.

UK and US researchers from Imperial College London, the Broad Institute of MIT and Harvard, 23andMe and the Michael J. Fox Foundation used gnomAD to study variants in the LRRK2 gene, which increases the risk of Parkinson’s. Previous studies have shown that blocking the protein formed by the gene can lead to organ damage in animals – but the scientists now suggest this approach should be safe for humans.

Research fellow Dr Nicky Whiffin said: “Large genetic databases are increasingly giving us a powerful insight into the likely impact of certain drugs. If we see that genetic variants that naturally reduce the amount of protein in our body do not result in severe diseases, we can be more confident that targeting that protein therapeutically will also be safe.”

For more information on the latest Parkinson’s research please visit the EPDA website.


Read more:

Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests

Can Covid-19 increase the risk of developing Parkinson’s?

Go Back

Share this story

Comments


Related articles


Lucilla-Bossi

Global update

Campaigners living with Parkinson’s invited to apply for US$20,000 award

2015 Bakken Invitation Award open for entries

READ MORE
Steve Sant CEO Parkinson’s Australia

In my country

Supporting 100,000 Australians with Parkinson’s

We spoke to the CEO of Parkinson’s Australia

READ MORE

Women and Parkinson's

7 famous women with Parkinson’s

Can you name a well-known woman with Parkinson’s?

READ MORE